NDAORALTABLET
Approved
Jun 2003
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
4/8 — Partial
STALEVO 50 (carbidopa, levodopa, and entacapone) by Orion Pharma is dopa decarboxylase inhibitors [moa]. Approved for aromatic amino acid decarboxylation inhibitor [epc]. First approved in 2003.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
STALEVO 50 is an oral tablet combining carbidopa, levodopa, and entacapone for the treatment of Parkinson's disease. Levodopa is converted to dopamine in the brain to restore motor function, while carbidopa prevents peripheral conversion and entacapone extends levodopa's duration by inhibiting catechol-O-methyltransferase. This fixed-dose combination simplifies dosing for patients requiring dopamine replacement therapy.
$0.04MPart D
LOE ApproachingDeclining
This low-spending SKU faces imminent loss of exclusivity with minimal market penetration, suggesting compressed margins and reduced team investment.
Mechanism of Action
DOPA Decarboxylase Inhibitors
Pharmacologic Class:
Aromatic Amino Acid Decarboxylation Inhibitor
Indications (1)
Career Relevance
STALEVO 50 offers limited career growth as a declining, low-revenue SKU approaching generic erosion with zero linked job opportunities. Professionals assigned to this product face compressed margin management and defensive strategy roles rather than growth initiatives, making it a stabilization assignment rather than a career accelerator.
Worked on STALEVO 50 at Orion Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.